According to BioNexus Gene Lab's latest financial reports the company's current revenue (TTM ) is S$12.44 Million. In 2023 the company made a revenue of S$12.9 Million a decrease over the revenue in the year 2022 that were of S$14.65 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.